Financial Architects, Inc Jazz Pharmaceuticals PLC Transaction History

Financial Architects, Inc

  • $657 Million
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$125.55 - $144.48 $376 - $433
-3 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$121.81 - $142.95 $365 - $428
3 New
3 $0
Q1 2018

Apr 23, 2018
SELL
$135.59 - $157.16 $135,590 - $157,160
-1,000 Closed
0 $0
Q4 2017

Feb 12, 2018
BUY
$131.06 - $150.39 $131,060 - $150,390
1,000
1,000 $135,000

Others Institutions Holding JAZZ

# of Institutions
511
Shares Held
57.7M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.94B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email